Predictive Oncology Inc. (POAI)
1.45
-0.08 (-5.23%)
At close: Mar 28, 2025, 3:59 PM
1.42
-2.10%
After-hours: Mar 28, 2025, 06:58 PM EDT
-5.23% (1D)
| Bid | 1.28 |
| Market Cap | 10.45M |
| Revenue (ttm) | 1.55M |
| Net Income (ttm) | -15.75M |
| EPS (ttm) | -2.96 |
| PE Ratio (ttm) | -0.49 |
| Forward PE | -11.33 |
| Analyst | n/a |
| Ask | 1.43 |
| Volume | 1,056,945 |
| Avg. Volume (20D) | 4,782,931 |
| Open | 1.43 |
| Previous Close | 1.53 |
| Day's Range | 1.27 - 1.52 |
| 52-Week Range | 0.55 - 3.06 |
| Beta | 1.22 |
About POAI
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery usi...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date May 3, 2010
Employees 34
Stock Exchange NASDAQ
Ticker Symbol POAI
4 days ago
+50.89%
Predictive Oncology shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago
-23.08%
Predictive Oncology shares are trading lower after the company announced a $545K registered direct offering.
